EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The structural basis of aldo-keto reductase 1C3 inhibition by 17α-picolyl and 17( E )-picolinylidene androstane derivatives

Jovana J Plavša-Puž, Jiří Brynda, Jovana J Ajduković, Sofija Bekić, Andjelka Ćelić, Pavlína Řezáčová, Jana Škerlová, Edward Petri

Journal of Enzyme Inhibition and Medicinal Chemistry · 2025

DOI: 10.1080/14756366.2025.2551979 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Enzyme Inhibition and Medicinal Chemistry, 2025. Verfasst von Jovana J Plavša-Puž und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology and Ecology, University of Novi Sad, Novi Sad, Serbia. Hauptthemen laut MEDLINE: Aldo-Keto Reductase Family 1 Member C3, Enzyme Inhibitors, Androstanes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science, Technological Development and Innovation of the Republic of Serbia, Provincial Secretariat for Higher Education and Scientific Research of the Autonomous Province of Vojvodina, National Institute for Cancer Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human aldo-keto reductase 1C3 (AKR1C3) is a steroid modifying enzyme involved in cancer progression. Here, A-ring modified 17α-picolyl and 17(E)-picolinylidene androstane derivatives are shown to inhibit AKR1C3 activity in vitro. None of the androstane derivatives have off-target affinity for the androgen receptor, based on a fluorescence assay in yeast cells. The X-ray structure of AKR1C3 in complex with the strongest inhibitor, a 17α-picolyl androstane with a C3-oxime modification, was determined at 1.7 Å resolution. Based on this crystal structure and molecular docking, inhibition of AKR1C3 by the 17α-picolyl or 17(E)-picolinylidene derivatives depends on interactions between the C3 modification and the NADP+ cofactor, while the C17α-picolyl or C17-picolinylidene group anchors the inhibitor to AKR1C3. Because one AKR1C3 inhibitor identified here was also previously reported to inhibit CYP17, it may be possible for future researchers to design dual AKR1C3/CYP17 inhibitors based on a steroid scaffold for potential treatment of advanced prostate cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aldo-Keto Reductase Family 1 Member C3Enzyme InhibitorsAndrostanesHumansStructure-Activity RelationshipMolecular StructureDose-Response Relationship, DrugMolecular Docking SimulationCrystallography, X-Ray

Stichwörter der Autor:innen

AKR1C3CYP17molecular dockingprostate cancerprotein X-ray crystallography

Substanzen

Aldo-Keto Reductase Family 1 Member C3Enzyme InhibitorsAndrostanesAKR1C3 protein, human

Autor:innen und Institutionen

  • Department of Biology and Ecology, University of Novi Sad, Novi Sad, Serbia.
  • Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences, Prague, Czech Republic.
  • Department of Chemistry, Biochemistry and Environmental Protection, University of Novi Sad, Novi Sad, Serbia.

Förderung

  • Ministry of Science, Technological Development and Innovation of the Republic of Serbia
  • Provincial Secretariat for Higher Education and Scientific Research of the Autonomous Province of Vojvodina
  • National Institute for Cancer Research
  • European Union – Next Generation EU

Zitieren

APA

Plavša-Puž, J. J., Brynda, J., Ajduković, J. J., Bekić, S., Ćelić, A., Řezáčová, P., Škerlová, J., & Petri, E. (2025). The structural basis of aldo-keto reductase 1C3 inhibition by 17α-picolyl and 17( E )-picolinylidene androstane derivatives. Journal of Enzyme Inhibition and Medicinal Chemistry. https://doi.org/10.1080/14756366.2025.2551979

Vancouver

Plavša-Puž JJ, Brynda J, Ajduković JJ, Bekić S, Ćelić A, Řezáčová P, et al. The structural basis of aldo-keto reductase 1C3 inhibition by 17α-picolyl and 17( E )-picolinylidene androstane derivatives. Journal of Enzyme Inhibition and Medicinal Chemistry. 2025. doi:10.1080/14756366.2025.2551979

BibTeX
@article{PlavaPu2025,
  author = {Plavša-Puž, Jovana J and Brynda, Jiří and Ajduković, Jovana J and Bekić, Sofija and Ćelić, Andjelka and Řezáčová, Pavlína and Škerlová, Jana and Petri, Edward},
  title = {The structural basis of aldo-keto reductase 1C3 inhibition by 17α-picolyl and 17( E )-picolinylidene androstane derivatives},
  journal = {Journal of Enzyme Inhibition and Medicinal Chemistry},
  year = {2025},
  doi = {10.1080/14756366.2025.2551979}
}
Kostenlos starten →